Brooks Laboratories Limited

BSE BROOKS.BO

Brooks Laboratories Limited Net Income Margin for the year ending March 31, 2024: -24.65%

Brooks Laboratories Limited Net Income Margin is -24.65% for the year ending March 31, 2024, a 50.41% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.
  • Brooks Laboratories Limited Net Income Margin for the year ending March 31, 2023 was -49.70%, a -131.86% change year over year.
  • Brooks Laboratories Limited Net Income Margin for the year ending March 31, 2022 was -21.44%, a 14.77% change year over year.
  • Brooks Laboratories Limited Net Income Margin for the year ending March 31, 2021 was -25.15%, a 28.67% change year over year.
  • Brooks Laboratories Limited Net Income Margin for the year ending March 31, 2020 was -35.26%, a -31.06% change year over year.
Key data
Date Net Income Margin EBITDA Margin EBIT Margin EBITDA
Market news
SV Wall Street
BSE: BROOKS.BO

Brooks Laboratories Limited

CEO Mr. Prashant Rathi
IPO Date Sept. 5, 2011
Location India
Headquarters 201, The Summit Business Park
Employees 293
Sector Health Care
Industries
Pharmaceuticals Drugstores & Retail Pharmacies
Description

Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. It offers liquid and dry powder injection, carbapenem drugs, tablets, dry syrup, and eye/ear drops. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.

StockViz Staff

February 2, 2025

Any question? Send us an email